מדינה: אוסטרליה
שפה: אנגלית
מקור: Department of Health (Therapeutic Goods Administration)
lidocaine hydrochloride, Quantity: 5 mg/mL
Aspen Pharmacare Australia Pty Ltd
Injection, solution
Excipient Ingredients: water for injections; sodium chloride; sodium hydroxide
Intravenous, Intramuscular, Epidural, Infiltration
5mL x 10, 5mL x 50
Medicine Registered
(S4) Prescription Only Medicine
XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block
Visual Identification: Clear, colourless solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1991-08-13
1 AUSTRALIAN PRODUCT INFORMATION XYLOCAINE AND XYLOCAINE WITH ADRENALINE Lidocaine (lignocaine) hydrochloride Lidocaine (lignocaine) hydrochloride with adrenaline (epinephrine) acid tartrate (Injection solutions for the production of local or regional anaesthesia) 1 NAME OF THE MEDICINE XYLOCAINE: lidocaine (lignocaine) hydrochloride XYLOCAINE with ADRENALINE: lidocaine (lignocaine) hydrochloride and adrenaline (epinephrine) acid tartrate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Plain aqueous solutions are sterile, isotonic and contain lidocaine (lignocaine) hydrochloride, sodium chloride, sodium hydroxide and/or hydrochloric acid for pH adjustment and water for injections. Lidocaine (lignocaine) hydrochloride with adrenaline (epinephrine) acid tartrate solutions are also sterile and isotonic, and in addition contain adrenaline (epinephrine) acid tartrate and sodium metabisulfite. Excipients with known effect: XYLOCAINE with ADRENALINE contains sulphites. XYLOCAINE solutions contain no antimicrobial agent and should be used only once and any residue discarded. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Clear, colourless solution for injection. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques: − infiltration, − intravenous regional anaesthesia – excluding solutions with adrenaline (epinephrine) acid tartrate, − peripheral nerve block such as intercostal block, − major plexus block such as brachial plexus block, − epidural block, − subarachnoid block. 4.2 D OSE AND METHOD OF ADMINISTRATION 2 The lowest dosage and volume that results in effective anaesthesia should be used and should be based on the status of the patient and the type of regional anaesthesia intended. XYLOCAINE solutions contain no antimicrobial agent and should be used only once and any residue discarded. Lidocaine (lignocaine) should be administered with great caution to קרא את המסמך השלם